Zoetis Inc. ZTS

Company Overview

Zoetis Inc. is a global animal health company focused on the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products, biologics, genetic tests, and precision animal health technologies for livestock and companion animals. The company operates within the broader animal health and veterinary pharmaceuticals industries and serves veterinarians, livestock producers, pet owners, and animal health distributors. Its primary revenue drivers include products for dogs, cats, cattle, swine, poultry, fish, and sheep, with companion animal products representing a significant and growing portion of revenue based on recent public filings and investor disclosures.

The company traces its origins to Pfizer’s animal health division, which was established in 1952. Zoetis became a standalone public company in 2013 following an initial public offering and subsequent separation from Pfizer. Since becoming independent, Zoetis has expanded through product innovation, acquisitions, and investment in diagnostics and digital veterinary technologies. The company is widely recognized for its diversified animal health portfolio, strong veterinary relationships, global manufacturing network, and recurring demand characteristics tied to companion animal care and food production industries.